NCT00004988View on ClinicalTrials.gov

Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium Bacteria

PHASE1CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

March 31, 2000

Study Completion Date

October 31, 2002

Conditions
CancerNeoplasmNeoplasm Metastasis
Interventions
DRUG

VNP20009

Trial Locations (1)

20892

National Cancer Institute (NCI), Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00004988 - Treatment of Patients With Cancer With Genetically Modified Salmonella Typhimurium Bacteria | Biotech Hunter | Biotech Hunter